Organovo Halts Liver Tissue R&D, Plans Restructuring to Cut Costs
Xconomy
AUGUST 7, 2019
Organovo says it has run out of money to advance its efforts to develop 3-D “patches” of living human liver tissue to tide over people waiting for an organ transplant. In the meantime, the company built a business as a contract research organization around its 3-D human tissue cultures, which pharma companies have used.
Let's personalize your content